451. Breaking dependency: strengthening the global tuberculosis response in the face of USAID cuts.
作者: Alimuddin Zumla.;Suvanand Sahu.;Dorothy Yeboah-Manu.;Delia Goletti.;Peter S Nyasulu.;Sayoki Mfinanga.;Mary Shilalukey-Ngoma.;Francine Ntoumi.;Alfonso J Rodriguez-Morales.;Dean B Everett.;Adeeba Kamarulzaman.;David S Hui.
来源: Lancet. 2025年405卷10483期958-961页 454. Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial.
作者: Roland Veltkamp.;Eleni Korompoki.;Kirsten H Harvey.;Emily R Harvey.;Cornelia Fießler.;Uwe Malzahn.;Viktoria Rücker.;Joan Montaner.;Valeria Caso.;Igor Sibon.;Peter Ringleb.;Omid Halse.;Klemens Hügen.;Sabine Ullmann.;Carolin Schuhmann.;Gabriele Putz Todd.;Kirsten Haas.;Elena Palà.;Stéphanie Debette.;Morgane Lachaize.;Tim D'Aoust.;Christian Enzinger.;Stefan Ropele.;Simon Fandler-Höfler.;Melanie Haidegger.;Yanzhong Wang.;Hatem A Wafa.;Virginia Cancelloni.;Maria Giulia Mosconi.;Gregory Y H Lip.;Deirdre A Lane.;Walter E Haefeli.;Kathrin I Foerster.;Viktoria S Wurmbach.;Peter Brønnum Nielsen.;Karim Hajjar.;Patrick Müller.;Sven Poli.;Jan Purrucker.;Mona Laible.;Lucio D'Anna.;Yolanda Silva.;Reyes de Torres Chacon.;Patricia Martínez-Sánchez.;Marion Boulanger.;Bo Norrving.;Guillaume Paré.;Rolf Wachter.;George Ntaios.;Charles D A Wolfe.;Peter U Heuschmann.; .
来源: Lancet. 2025年405卷10482期927-936页
Direct oral anticoagulants (DOACs) reduce the rate of thromboembolism in patients with atrial fibrillation but the benefits and risks in survivors of intracerebral haemorrhage are uncertain. We aimed to determine whether DOACs reduce the risk of ischaemic stroke without substantially increasing the risk of recurrent intracerebral haemorrhage.
456. Feeding dystonia, chorea, psychosis, and self-mutilation in an African patient with neuroacanthocytosis syndrome.
作者: Maouly Fall.;Moussa Seck.;Alassane Mamadou Diop.;Jamil Kahwagi.;Grace Tsemo Yimta.;Allé Guéye.;Pedro Rodriguez Cruz.;Mie Rizig.
来源: Lancet. 2025年 457. A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study.
作者: John M Dennis.;Katherine G Young.;Pedro Cardoso.;Laura M Güdemann.;Andrew P McGovern.;Andrew Farmer.;Rury R Holman.;Naveed Sattar.;Trevelyan J McKinley.;Ewan R Pearson.;Angus G Jones.;Beverley M Shields.;Andrew T Hattersley.; .
来源: Lancet. 2025年405卷10480期701-714页
Data to support individualised choice of optimal glucose-lowering therapy are scarce for people with type 2 diabetes. We aimed to establish whether routinely available clinical features can be used to predict the relative glycaemic effectiveness of five glucose-lowering drug classes.
458. 20th anniversary of the WHO Framework Convention on Tobacco Control coming into force: time for a step change in ambition.
作者: Anna B Gilmore.;Cynthia Callard.;Deborah Sy.;Blanca A Llorente.;Upendra Bhojani.;Catherine O Egbe.;Stella Aguinaga Bialous.
来源: Lancet. 2025年405卷10480期677-681页 |